AlphaTON Capital Corp. (ATON)
| Market Cap | 21.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.77M |
| Shares Out | 6.35M |
| EPS (ttm) | -5.72 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 62,878 |
| Open | 3.570 |
| Previous Close | 3.520 |
| Day's Range | 3.231 - 3.720 |
| 52-Week Range | 2.950 - 15.818 |
| Beta | 0.37 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 28, 2025 |
About ATON
AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. Its activities cover network validation and staking operations, and development of Telegram-based applications, as well as strategic investments in TON-based decentralized finance protocols, gaming platforms, and bu... [Read more]
Financial Performance
Financial StatementsNews
AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram's Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem
Strategic Partnership Brings Sustainable, Decentralized Computing Power to Privacy-Preserving AI Through Hydroelectric-Powered Data Centers Strategic Partnership Brings Sustainable, Decentralized Comp...
AlphaTON's Cyncado Therapeutics and Australia's ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans
Dover, DE and Sydney, Australia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado T...
AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De'Ath as Chief Partnership Officer
Driving Global Partnerships, Institutional Adoption, and TON Mastercard Launch Driving Global Partnerships, Institutional Adoption, and TON Mastercard Launch
Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado's A2B and A2A Receptor Antagonists and Cancer Vaccines
Dover, DE, Nov. 07, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) (“AlphaTON”) and its wholly owned oncology subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics (“Cyn...
AlphaTON Capital to Acquire Premier Crypto Newswire Blockchain Wire, Cementing Dominance in Digital Asset Communications via the Telegram Ecosystem
The Acquisition focuses the Top Crypto News Platform to Expand Verifiable News Distribution to Telegram's 1+ Billion Users The Acquisition focuses the Top Crypto News Platform to Expand Verifiable New...
Brittany Kaiser to Present at SALT London 2025 on DeFi, Tokenization, and Digital Asset Treasuries
Part of AlphaTON Capital's global investor roadshow and world tour, bridging crypto innovation with traditional finance across major financial hubs Part of AlphaTON Capital's global investor roadshow ...
AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard
Partnership Brings First Mastercard-Approved TON Card Program Enabling Native Cryptocurrency Spending from Digital Wallets with ALT5 Integration Partnership Brings First Mastercard-Approved TON Card P...
AlphaTON Capital Kicks Off Global World Tour with Investor Breakfast at Nasdaq MarketSite
Event to Feature Brittany Kaiser, Enzo Villani, and Michael Terpin Introducing “A New Frontier in Open Finance” Event to Feature Brittany Kaiser, Enzo Villani, and Michael Terpin Introducing “A New Fr...
AlphaTON Capital Announces Strategic Investment in GPU Infrastructure to Power Cocoon Decentralized AI Network
Company to Deploy Significant GPU and Data Center Resources Following Cocoon's Launch Announcement at Blockchain Life Company to Deploy Significant GPU and Data Center Resources Following Cocoon's Lau...
AlphaTON Capital CEO Brittany Kaiser to Speak at “Future of Money, Governance, and the Law” Summit on Capitol Hill, October 30, 2025
Washington, DC, Oct. 27, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (NASDAQ: ATON) is proud to announce that Brittany Kaiser, CEO, will be a featured speaker at the Future of Money, Governance, and the...
AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4's Path to First- Patient Dosing
Poster presented today in Boston shows direct anti-tumor activity in mesothelioma models, reduced tumor PD-L1 alongside decreased pCREB, and strong TT-4 monotherapy activity with added benefit in anti...
AlphaTON Capital Joins Blockchain Game Alliance (BGA)
Move Deepens Telegram/TON Gaming Strategy Following Intent to Acquire 51% of GAMEE Move Deepens Telegram/TON Gaming Strategy Following Intent to Acquire 51% of GAMEE
AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
Abstract published today reports reduced adenosine-mediated PD-L1 in a human epithelioid mesothelioma cell line linked to decreased CREB phosphorylation (pCREB). In vivo, TT-4 monotherapy outperformed...
Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican's 10th Anniversary World Changers Summit
Vatican City, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Enzo Villani, Chief Investment Officer of AlphaTON Capital ( NASDAQ: ATON), has been invited to speak at the 10th Anniversary of the IASC World Changer...
AlphaTON Capital Powers TOKEN2049 “Origins” Hackathon in Singapore
Awards $25,000 Prize Pool to Global TON Builders Across AI, Payments, and Infrastructure Awards $25,000 Prize Pool to Global TON Builders Across AI, Payments, and Infrastructure
How AlphaTON (ATON) is Funding Cancer Research Through Tokenization
Anthony Scaramucci and Brittany Kaiser explain how AlphaTON are using digital assets to fund cancer research and launch companies within blockchain and the “Telegram ecosystem.” AlphaTON (ATON) owns m...
AlphaTON Capital CEO Brittany Kaiser and SkyBridge Capital Founder Anthony Scaramucci Join Schwab Network's Trading 360 to Discuss Crypto Innovation and Cancer Research Funding
Dover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) today announced that its CEO, Brittany Kaiser, will appear alongside Anthony Scaramucci, Founder of SkyBridge Capital...
AlphaTON Capital Launches AI Vertical with MorpheusAI to Accelerate Agentic AI Development on TON and Telegram
Landmark Strategic Partnership Establishes Morpheus as Preferred AI Infrastructure Provider for AlphaTON's Portfolio Companies Landmark Strategic Partnership Establishes Morpheus as Preferred AI Infra...
AlphaTON Capital CIO and Executive Chairman Enzo Villani Featured in Live Interview at Nasdaq MarketSite with IPO Edge
Dover, DE, Oct. 09, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON), a specialized digital asset treasury company focused on the TON blockchain and Telegram ecosystem, today announced t...
AlphaTON Capital and Subsidiary Cyncado Therapeutics Pioneer Convergence of Digital Assets and Oncology Innovation: Exploring Tokenization Framework for Mesothelioma Program as it Advances Toward Q1 2026 First Patient Dosing
Dover, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) ("AlphaTON" or the "Company"), alongside its wholly owned oncology subsidiary Tarus Therapeutics, LLC (dba Cyncado The...
Animoca Brands and AlphaTON Capital announce equity and token investments; AlphaTON intends to acquire GAMEE
Singapore, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Animoca Brands, the company driving digital property rights to help establish the open metaverse and its associated network effects, and AlphaTON Capital ...
Health In Tech and AlphaTON Capital Sign Strategic Letter of Intent to Develop HITChain
an innovative blockchain- powered healthcare insurance claims processing platform built on The Open Network (TON). STUART, Fla.
AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition
DOVER, Del., Sept. 25, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (Nasdaq: ATON), a specialized digital asset treasury company focused on the Telegram ecosyst...
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram's Billion-User Ecosystem Brittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appointe...
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025
DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Is...